AI Impact on Pharmaceutical Pricing and Reimbursement - BCC Pulse Report
AI Impact on Pharmaceutical Pricing and Reimbursement - BCC Pulse Report
Report Includes
- Impact analysis of artificial intelligence (AI) on the pharmaceutical pricing and reimbursement market
- Case studies of the successful integration of AI and machine learning in automated health Technology assessment (HTA) evidence, drug price forecasting and market access planning, fraud, waste, and abuse detection, personalized and value-based pricing models
- Highlights of AI adoption trends across major geographical regions, as well as disruptions caused by AI in pharmaceutical pricing and reimbursement workflows, Health Technology Assessment (HTA) Dossier Generation and Evidence Synthesis, Real-World Evidence (RWE) Generation, International Reference Pricing (IRP) Simulation, Fraud, Waste, and Abuse (FWA) Detection in Claims Management, Utilization Management and Prior Authorization Automation and Rebate Optimization
- Review of the impact of AI on various stages of the pharmaceutical pricing and reimbursement market's value chain, along with a supply chain analysis
- Competitive landscape featuring key strategic initiatives, market spending and an investment outlook